Applying low coverage whole genome sequencing to detect malignant ovarian mass

To evaluate whether low coverage whole genome sequencing is suitable for the detection of malignant pelvic mass and compare its diagnostic value with traditional tumor markers. We enrolled 63 patients with a pelvic mass suspicious for ovarian malignancy. Each patient underwent low coverage whole gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ming, Zhong, Pengqiang, Hong, Mengzhi, Tan, Jinfeng, Yu, Xuegao, Huang, Hao, Ouyang, Juan, Lin, Xiaoping, Chen, Peisong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394143/
https://www.ncbi.nlm.nih.gov/pubmed/34446054
http://dx.doi.org/10.1186/s12967-021-03046-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394143/
https://www.ncbi.nlm.nih.gov/pubmed/34446054
http://dx.doi.org/10.1186/s12967-021-03046-3

Ejemplares similares